A phase I study of bevacizumab in combination with niraparib in patients with platinum-sensitive epithelial ovarian cancer: The ENGOT-OV24/AVANOVA1 trial.
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5555-5555
◽
Keyword(s):
Phase I
◽
2019 ◽
Vol 15
(6)
◽
pp. 1201
◽
2018 ◽
Vol 83
(1)
◽
pp. 97-105
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 5517-5517
◽